[CYCC] QoQ Quarter Result on 31-Mar-2022 [#Q1]

Stock
[CYCC] Cyclacel Pharmaceuticals, Inc.
Announcement Date
12-May-2022
Financial Year
2022
Quarter
31-Mar-2022 [#Q1]
Profit Trend
QoQ- 22.40%
YoY- -18.11%
Quarter Report
CYCC's Result
CYCC's Financial Summary
View:
Show?
Quarter Result
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
Revenue 0 0 0 0 0 0 0 -
PBT -9,000 -6,110 -5,559 -5,246 -6,491 -5,985 -6,091 29.63%
Tax -1,581 -1,014 -984 -1,138 -1,197 -998 -964 38.94%
NP -7,419 -5,096 -4,575 -4,108 -5,294 -4,987 -5,127 27.84%
Tax Rate - - - - - - - -
Total Cost 7,419 5,096 4,575 4,108 5,294 4,987 5,127 27.84%
Ratio Analysis
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
EPS -8.87 -0.41 -0.45 -0.41 -0.54 -0.53 -0.56 527.53%
EPS Diluted -8.87 -0.41 -0.45 -0.41 -0.54 -0.53 -0.56 527.53%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.